Copyright
©The Author(s) 2020.
World J Clin Cases. Nov 6, 2020; 8(21): 5116-5127
Published online Nov 6, 2020. doi: 10.12998/wjcc.v8.i21.5116
Published online Nov 6, 2020. doi: 10.12998/wjcc.v8.i21.5116
Table 5 The Cox regression models for normal size ovarian cancer syndrome-specific survival in the multivariate analysis
Factors | Overall survival | ||
HR | 95%CI | P value | |
CA125 ≥ 100 in U/mL | 0.785 | 0.093-6.589 | 0.823 |
CA199 ≥ 35 in U/mL | 3.004 | 1.133-7.960 | 0.027 |
Ascites ≥ 1000 in mL | 1.935 | 0.814-4.599 | 0.135 |
Residual tumor | 1.417 | 0.492-4.078 | 0.518 |
Chemotherapy numbers ≥ 6 | 0.313 | 0.127-0.770 | 0.012 |
Histological subtype | 1.124 | 0.744-3.451 | 0.235 |
Stage | 0.769 | 0.642-3.477 | 0.176 |
Operation method | 1.213 | 0.984-3.461 | 0.115 |
- Citation: Yu N, Li X, Yang B, Chen J, Wu MF, Wei JC, Li KZ. Clinical characteristics and survival of patients with normal-sized ovarian carcinoma syndrome: Retrospective analysis of a single institution 10-year experiment. World J Clin Cases 2020; 8(21): 5116-5127
- URL: https://www.wjgnet.com/2307-8960/full/v8/i21/5116.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i21.5116